NASDAQ: CRACUCrown Reserve Acquisition Corp I Stock
$10.10+0.01 (+0.1%)
Updated Nov 11, 2025
CRACU Price
$10.10
Fair Value Price
N/A
Market Cap
N/A
52 Week Low
$10.04
52 Week High
$10.10
P/E
N/A
P/B
N/A
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
N/A
Earnings
N/A
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
7.72
Operating Cash Flow
N/A
Beta
0.15
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
CRACU Overview
A blank‑check SPAC (Special Purpose Acquisition Company), incorporated in the Cayman Islands on April 29, 2025, aiming to complete a merger or acquisition in healthcare-related sectors such as pharmaceuticals, med-tech, medical equipment, or healthcare IT
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine CRACU's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Shell Company
Industry Rating
F
CRACU
Ranked#18 of 33
Ranked#18 of 33
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $11.24 | C | |
| $10.14 | C | |
| $10.05 | C |
Be the first to know about important CRACU news, forecast changes, insider trades & much more!
CRACU News
Overview
Due Diligence Score
–
Industry Average (6)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how CRACU scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
CRACU's debt to equity ratio (7.72) is considered high
Healthy Debt to Equity Financials
Insufficient data to perform Discounted Cash Flow valuation for CRACU
Below Fair Value Valuation
Insufficient data to perform Discounted... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
There are 30 more CRACU due diligence checks available for Premium users.
Valuation
CRACU's financial health
Profit margin
Revenue
$0.0
Net Income
$0.0
Profit Margin
0%
Assets to liabilities
Assets
$218.0k
Liabilities
$193.0k
Debt to equity
7.72
CRACU's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$0.0
Investing
$0.0
Financing
$25.0k
Crown Reserve Acquisition I Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.